This winter, the annual outbreak of bronchiolitis among infants has shaken French hospitals like never before. In a delicate context characterized by a shortage of caregivers, the strength of the wave has put the health care system under great strain. Although this common respiratory infection is usually mild, it still sends 2% to 3% of children under the age of 1 to the hospital. Deaths are also to be regretted every year.
In this context, the prospect of a vaccine to protect the youngest from RSV (respiratory syncytial virus), a major cause of bronchiolitis in children, is a long-awaited holy grail for caregivers and parents. Research teams have mobilized on this topic for decades, and persistence finally seems to be paying off, as no less than two treatments (a maternal vaccine that allows the mother to pass her antibodies to the baby in the womb, and a monoclonal antibody for infants. ) should be available…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.